UPDATE: 2/7/2023—USTR is extending the 81 medical product exclusions until May 15, according to a Federal Register publication notice.
The Office of the U.S. Trade Representative (USTR) is extending exclusions of 81 medical-care products from Section 301 China tariffs until February 28, 2023. USTR felt this determination was warranted to continue combatting the needs from the COVID-19 pandemic.
If you have questions about these extensions and how they impact your business, reach out to Mohawk Global Trade Advisors.